Functional assessment in bone - osteoclast markers
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2016
Price : $35 *
At a glance
- Drugs Maraciclatide (Primary)
- Indications Osteitis deformans
- Focus Diagnostic use
- Acronyms FAB-O study
- 04 Nov 2015 Accrual to date is 8% according to United Kingdom Clinical Research Network record.
- 16 Oct 2015 Status changed from not yet recruiting to recruiting as reported by United Kingdom Clinical Research Network.
- 11 Sep 2014 New trial record